Arkolith/Insider Trading/BCAX/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Mar 2, 2026
Net Buying
Open-Market Buys
$4.8M
Open-Market Sells
$0
Net Open-Market Flow
$4.8M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Buy(P)300K$16.00$4.8M4.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Buy(P)2.2M$16.00$35.2M2.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000231) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML